Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Sicilian network"'
Autor:
Fabio Salvatore Macaluso, Gaetano Inserra, Marco Ventimiglia, Maria Cappello, Mario Cottone, Antonio Carroccio, Angela Alibrandi, Antonino Carlo Privitera, Walter Fries, Filippo Mocciaro, N. Belluardo, A. Magnano, Sara Renna, S. Siringo, S. Garufi, Serena Porcari, C. Ferracane, Ambrogio Orlando, Alessandro Vitello, C. Bertolami, Oriana Fidanza, Roberto Di Mitri, Anna Viola, G. Magrì
Publikováno v:
Drugs & Aging. 37:383-392
BACKGROUND AND OBJECTIVE: Older people with inflammatory bowel disease (IBD) appear to have a lower response to anti-tumour necrosis factor (TNF) therapy, with more frequent complications than younger patients. The objective of this study was to asse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::836e9cf59f5bc6b58e1d561e5ee90fac
https://doi.org/10.1007/s40266-020-00744-3
https://doi.org/10.1007/s40266-020-00744-3
Autor:
Orlando, A., Macaluso, F., Fries, W., Privitera, A., Cappello, M., Siringo, S., Inserra, G., Magnano, A., Di Mitri, R., Belluardo, N., Scarpulla, G., Magrì, G., Trovatello, N., Carroccio, A., Genova, S., Bertolami, C., Vassallo, R., Ventimiglia, M., Renna, S., Orlando, R., Rizzuto, G., Cottone, M.
Background: In the absence of head-to-head trials, there is an unmeet need to better understand the relative effectiveness of different biologics in inflammatory bowel disease (IBD). The Sicilian Network for Inflammatory Bowel Disease (SN-IBD) is a g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::021de99063e3f7a66b81d31bc229df9e
https://hdl.handle.net/10447/279359
https://hdl.handle.net/10447/279359
Autor:
Orlando A., Macaluso F. S., Fries W., Privitera A. C., Cappello M., Siringo S., Inserra G., Magnano A., Di Mitri R., Belluardo N., Scarpulla G., Magrì G., Trovatello N., Carroccio A., Genova S., Calandruccio G., Vassallo R., Romano C., Pellegrino S., Citrano M., Accomando S., Ventimiglia M., Renna S., Orlando R., Rizzuto G., Vinci E., Cottone M.
Background: The monitoring of appropriateness, costs, and clinical outcomes of biological therapy in inflammatory bowel disease (IBD) is a relevant need. We aimed to evaluate all these issues in Sicily through a web based network of all prescribing c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::446fb2bc730944ab5a63283393a6c87d
http://hdl.handle.net/10447/279357
http://hdl.handle.net/10447/279357
Autor:
Orlando A., Fries W., Privitera A., Cappello M., Siringo S., Inserra G., Magnano A., Di Mitri R., Belluardo N., Scarpulla G., Magrì G., Trovatello A., Carroccio A., Genova S., Calandruccio G., Vassallo R., Romano C, Magazzù G., Citrano M., Accomando S., Ventimiglia M., Renna S., Orlando R., Rizzuto G., Vinci E., Macaluso F. S., Cottone M.
Background and aim: The monitoring of appropriateness and costs of biological therapy in Inflammatory bowel disease (IBD) is a relevant need. We aimed to evaluate appropriateness, efficacy and safety of biological therapy in IBD in Sicily through a w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::8bd5ec51ff66efb7f9d2dd301992f619
http://hdl.handle.net/10447/279361
http://hdl.handle.net/10447/279361
Autor:
Renna, S., Mocciaro, F., Ventimiglia, M., Macaluso, F., Orlando, R., Billeci, M., Cappello, M., Mendolaro, M., Privitera, A., Ferracane, C., Fries, W., Pisana, V., Magnano, A., Pluchino, D., Inserra, G., Scarpulla, G., Garufi, S., Carroccio, A., Siringo, S., Dimitri, R., Cottone, M., Orlando, A.
Introduction: Adalimumab (ADA) and golimumab (GOL) are effective in the induction and maintenance treatment of moderate-to-severe ulcerative colitis (UC). No comparable data between the 2 drugs are available up to now. Aims & Methods: We reported the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::383eb6fd471e3ece82699b0ac2792c21
http://hdl.handle.net/10447/279365
http://hdl.handle.net/10447/279365
Autor:
Orlando, A., Macaluso, F., Fries, W., Privitera, A., Cappello, M., Siringo, S., Inserra, G., Magnano, A., Di Mitri, R., Belluardo, N., Scarpulla, G., Magrì, G., Trovatello, A., Carroccio, A., Genova, S., Bertolami, C., Vassallo, R., Romano, C., Pellegrino, S., Citrano, M., Accomando, S., Ventimiglia, M., Renna, S., Orlando, R., Rizzuto, G., Vinci, E., Cottone, M.
Introduction: The monitoring of appropriateness, costs, and clinical outcomes of biological therapy in inflammatory bowel disease (IBD) is a relevant need. Aims & Methods: We aimed to evaluate all these issues in Sicily through a webbased network of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1949eb087a7c4f0838e8b66d1d786271
http://hdl.handle.net/10447/279363
http://hdl.handle.net/10447/279363